New IAVI Analysis Examines Vaccine’s Potential Role In Ending AIDS Epidemic

Global Health Technologies Coalition’s “Breakthroughs”: A vaccine is essential to conclusively end HIV/AIDS: New modeling data catalyzes conversations around the end of HIV/AIDS and a vaccine’s role in getting there
“In this guest post Tom Harmon, senior policy analyst at the International AIDS Vaccine Initiative (IAVI), highlights a new analysis exploring the critical role of a vaccine in ending AIDS.” Harmon notes, “Under our base scenario, a vaccine of 70 percent efficacy with strong uptake would reduce HIV infections in [low- and middle-income countries (LMICs)] by 44 percent in its first 10 years and by 65 percent in 25 years, ultimately averting tens of millions of infections and saving millions of lives…” (2/18).